Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Buy
120,199
+10,379
+9% +$1.12M ﹤0.01% 1454
2026
Q1
$11.3M Buy
109,820
+2,200
+2% +$224K ﹤0.01% 1478
2025
Q4
$10.8M Buy
107,620
+15,987
+17% +$1.58M ﹤0.01% 1512
2025
Q3
$7.92M Sell
91,633
-1,140
-1% -$90.1K ﹤0.01% 1676
2025
Q2
$7.08M Buy
92,773
+8,797
+10% +$644K ﹤0.01% 1712
2025
Q1
$5.96M Sell
83,976
-644
-0.8% -$50.4K ﹤0.01% 1830
2024
Q4
$6.62M Buy
84,620
+833
+1% +$77.8K ﹤0.01% 1843
2024
Q3
$8.57M Sell
83,787
-22,283
-21% -$1.85M ﹤0.01% 1708
2024
Q2
$8.05M Buy
106,070
+41,862
+65% +$2.98M ﹤0.01% 1710
2024
Q1
$4.82M Buy
64,208
+127
+0.2% +$10.1K ﹤0.01% 2010
2023
Q4
$4.72M Buy
64,081
+3,458
+6% +$214K ﹤0.01% 2014
2023
Q3
$2.79M Sell
60,623
-399
-0.7% -$17.7K ﹤0.01% 2157
2023
Q2
$2.57M Buy
61,022
+4,402
+8% +$166K ﹤0.01% 2239
2023
Q1
$1.48M Sell
56,620
-3,827
-6% -$113K ﹤0.01% 2460
2022
Q4
$1.8M Buy
60,447
+22,995
+61% +$641K ﹤0.01% 2436
2022
Q3
$728K Sell
37,452
-4,039
-10% -$67.6K ﹤0.01% 2866
2022
Q2
$563K Buy
41,491
+14,965
+56% +$158K ﹤0.01% 2982
2022
Q1
$319K Buy
26,526
+10,777
+68% +$157K ﹤0.01% 3113
2021
Q4
$311K Hold
15,749
﹤0.01% 3173
2021
Q3
$355K Buy
+15,749
New +$457K ﹤0.01% 3228

Other funds holding NUVL

Nuveen's NUVL Position: Q2 2026 in Review

Nuveen increased its Nuvalent (NUVL) stake by 9.5% in Q2 2026, buying an estimated $1.12M and bringing the position to 120,199 shares worth $14.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

Nuveen first reported a position in NUVL in Q3 2021 and has held it in 20 quarters since. 292 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Nuveen held 120,199 shares of Nuvalent worth $14.8M as of Q2 2026.
  • Nuveen bought 10,379 Nuvalent shares in Q2 2026, an estimated $1.12M.
  • Nuvalent made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1454 holding.
  • Nuveen first reported a position in Nuvalent in Q3 2021 and has held it in 20 quarters since.
  • 292 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.